 | 09/08/2010 09:00:28 AM
ANAVEX TO PRESENT AT RODMAN&RENSHAW HEALTHCARE CONFERENCE SEPTEMBER 13 IN NEW YORK CITY
CALIFON, NJ, Sept. 8 Dr. Cameron Durrant, Executive Chairman of Anavex Life Sciences Corp., will be presenting at the Rodman&Renshaw 12th Annual Healthcare Conference at 4:45 pm ET on Monday, September 13, 2010 in New York City.
[PR Newswire] |
| 09/08/2010 09:00:07 AM
BioMimetic Therapeutics PMA Remains on Track
Augment Injectable Receives Device Designation. United States and European Patent Portfolio Significantly Enhanced.
[Business Wire] |
| 09/08/2010 08:59:13 AM
Perrigo gets FDA approval for generic Aldara Cream
ALLEGAN, Mich. Aldara, made by Graceway Pharmaceuticals, is also used for superficial basal cell carcinoma and external genital and perianal warts in patients 12 years old or older. In addition to making pharmaceutical products, Perrigo, which is based in Allegan, Mich., makes infant formulas, nutritional products and pharmaceutical and medical diagnostic products.
[Associated Press] |
| 09/08/2010 08:48:18 AM
BRIEF: Man arrested on charges he was manufacturing meth
Sept. 07--BROOKSVILLE -- A man is facing drug manufacturing and possession charges after deputies responded to a tip that he was "cooking" meth in his home.
[Hernando Today (Brooksville, FL)] |
| 09/08/2010 08:30:52 AM
Intellect Neurosciences Issues Letter to Shareholders
Intellect Neurosciences, Inc., a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic agents for the treatment and prevention of Alzheimer's disease, with an internal diversified pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, today issued the following Letter to Shareholders from Dr. Danie...
[GlobeNewswire] |
| 09/08/2010 08:30:40 AM
Health Enhancement Products Signs Multi-Million Dollar Exclusive, Worldwide Distribution Agreement
Health Enhancement Products, Inc. today announced it has executed a multi-year exclusive worldwide distribution agreement regarding its ProAlgaZymeŽ product with an international distributor of health and nutritional products.
[GlobeNewswire] |
| 09/08/2010 08:30:29 AM
Curaxis Pharmaceutical Corp CEO Patrick S. Smith Announces Plans for Further Clinical Trials for Alzheimer's Treatment
Curaxis Pharmaceutical Corp today announced an update on the Company's clinical development plans for Memryte, its candidate to treat mild-to-moderate Alzheimer's disease.
[GlobeNewswire] |
| 09/08/2010 08:30:28 AM
iPierian Announces Second Close of $28 Million Series B Financing
SOUTH SAN FRANCISCO, Calif., Sept. 8 iPierian, Inc., the leading biopharmaceutical company using patient-derived induced pluripotent stem cells for drug discovery, today announced the second closing of its Series B equity financing, bringing the total amount raised in this round to $28 million.
[PR Newswire] |
| 09/08/2010 08:30:27 AM
Access Pharmaceuticals to Present At Rodman&Renshaw Annual Global Investment Conference in New York City
DALLAS and NEW YORK, Sept. 8 ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company specializing in products for cancer, supportive care, today announced that the Company will present at the Rodman&Renshaw Annual Healthcare Conference in New York City on Tuesday, September 14th at 9:35AM ET in the Fahnestock Salon, located on the 5th floor of the New York Palace Hotel.
[PR Newswire] |
| 09/08/2010 08:30:26 AM
Zyngenia, Inc. Raises $15 Million in Series A Extension Financing
GAITHERSBURG, Md., Sept. 8 Zyngenia, Inc., a privately held biotherapeutics company focused on next-generation antibody drug development, announced today the completion of a $15 million Series A financing extension from New Enterprise Associates, one of the world's leading venture capital firms.
[PR Newswire] |
| 09/08/2010 08:30:21 AM
Medidata Solutions to Present at Key Events in September
Clinical Trial Technology Leaders to Share Expertise on Post-Approval Studies, Trial Budgeting and Clinical System Integrations.
[n/a] |
| 09/08/2010 08:19:10 AM
QVARŽ Versus Fluticasone in a Real-World Study Highlights the Importance of Inhaled Corticosteroid (ICS) Choice in Achieving Asthma Control
HORSHAM, Pa., Sept. 8 Teva Pharmaceutical Industries Ltd. today announced the publication of results from a real-life observational study of the General Practice Research Database, which revealed that asthma patients treated with QVARŽ, either as initial therapy or with an increase in dose, had a similar or better chance of achieving asthma control as patients who were treated with fluticasone ...
[PR Newswire] |
| 09/08/2010 08:10:45 AM
New Equipment Can Help Researchers Brew Biofuel
Clemson University issued the following news release: A new piece of equipment for the Clemson University biosystems engineering program will help researchers conduct novel research on new biomass sources, such as algae and fungi, that may supply biofuels of the future.
[Targeted News Service] |
| 09/08/2010 08:02:28 AM
National Science Foundation Awards URI $20 Million to Stimulate Marine Life Science Research in Rhode Island
The University of Rhode Island issued the following news release: The National Science Foundation has awarded the University of Rhode Island a $20 million grant designed to stimulate research in marine life science at nine of the state's institutions of higher education.
[Targeted News Service] |
| 09/08/2010 08:02:00 AM
INC Research to Present Value of Strategic Alliances for CROs and Sponsors in Exclusive Online Webinar
09/08/10 -- INC Research Ž, a therapeutically focused contract research organization with a trusted process for delivering reliable results, is hosting an upcoming thought-leading webinar on "The Value of Strategic Alliances vs.
[Market Wire] |
| |
previous
|
next |
